Key facts
- This page summarizes Gregoire Ramade's Form 4 filing for VAPOTHERM INC.
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Jan 2023, 16:49.
Gregoire Ramade - 02 Jan 2023 Form 4 Insider Report for VAPOTHERM INC
- Reporting relationship
- SVP & Chief Commercial Officer
- Issuer ticker
- N/A
- Reported as of
- 02 Jan 2023
- Net transaction value
- +$14,364
- SEC form
- 4
- Accepted by SEC
- 04 Jan 2023, 16:49:06 UTC
- Prior SEC filing
- 17 Nov 2022
- Next SEC filing
- 03 Dec 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/Adrain Bryant, as Attorney In Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Gregoire Ramade filed Form 4 for VAPOTHERM INC on 04 Jan 2023.
Change
- Previous filing in this sequence was filed on 17 Nov 2022.
- Current net transaction value: +$14,364.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VAPO
transaction
Common Stock
Award
- Transaction value
- $14,364
- Shares
- +5,320
- Change %
- +6.4%
- Price
- $2.70
- Shares after
- 88,434
- Date
- 02 Jan 2023
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VAPO
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +54,675
- Change %
- Price
- $0.000000
- Shares after
- 54,675
- Date
- 02 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 54,675
- Exercise price
- $2.70
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Restricted stock unit award granted under the Vapotherm, Inc. Amended and Restated 2018 Equity Incentive Plan (the "2018 Equity Plan") and the Vapotherm, Inc. Amended and Restated 2019 French Qualifying Sub Plan (the "French Sub Plan") in lieu of an annual increase in the reporting person's 2023 base salary. The restricted stock unit award will vest in full on December 31, 2023, subject to the reporting person's continued service as an employee or other service provider to the Issuer through the vesting date.
Footnote F2
Includes 58,553 shares that will be issued over time upon vesting and settlement of restricted stock unit awards.
Footnote F3
This option was granted under the 2018 Equity Plan and the French Sub Plan and will vest as to 25% of the underlying shares on January 2, 2024, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, subject to the reporting person's continued service as an employee or other service provider to the Issuer through the vesting dates.